Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria

Clinical Infectious Diseases

Volumn 51, Issue 12, 2010, Pages

  Bethell, Delia ^a   Se, Youry ^a   Lon, Chanthap ^a   Socheat, Duong ^b   Saunders, David ^a   Teja Isavadharm, Paktiya ^a   Khemawoot, Phisit ^a   Darapiseth, Sea ^b   Lin, Jessica ^a   Sriwichai, Sabaithip ^a   Kuntawungin, Worachet ^a   Surasri, Sittidech ^a   Lee, Sue J ^c   Sarim, Ses ^d   Tyner, Stuart ^a   Smith, Bryan ^a   Fukuda, Mark M ^a  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Center for Parasitology Entomology and Malaria Control   (Cambodia)

^c MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^d Tasanh Health Center   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALUMINUM; ARTESUNATE; CALCIUM CARBONATE; CALCIUM GLUBIONATE; CEFTRIAXONE; CHLORAMPHENICOL; CHLORPHENIRAMINE; CIMETIDINE; CIPROFLOXACIN; DIMENHYDRINATE; DOMPERIDONE; DOXYCYCLINE; FERROUS SULFATE; GLUCONIC ACID; MEBENDAZOLE; METOCLOPRAMIDE; MULTIVITAMIN; PARACETAMOL; QUININE; RANITIDINE; TETRACYCLINE;

ADULT; ARTICLE; BLOOD CELL COUNT; CAMBODIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG CLEARANCE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GEOMETRY; HUMAN; MALARIA FALCIPARUM; MALE; MONOTHERAPY; NEUTROPENIA; NEUTROPHIL COUNT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; CAMBODIA; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NEUTROPENIA; YOUNG ADULT;

EID: 78649868979     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/657402     Document Type: Article

References (17)

1. World Health Organization. Guidelines for the treatment of malaria. 1st ed. Geneva: World Health Organization, 2006.
2. Brewer TG, Genovese RF, Newman DB, Li Q. Factors relating to neurotoxicity of artemisinin antimalarial drugs "listening to arteether." Med Trop (Mars) 1998; 58:22-27.
3. Gordi T, Lepist EI. Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol Lett 2004; 147:99-107.
4. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361:455-467.
5. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008; 359:2619-2620.
6. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94(suppl 1):S1-S90.
7. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13:176-181. (Pubitemid 36962641)
8. Price R, van Vugt M, Phaipun L, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 1999; 60:547-555.
9. Taylor WR, White NJ. Antimalarial drug toxicity: a review. Drug Saf 2004; 27:25-61.
10. Teja-Isavadharm P, Siriyanonda D, Siripoksaupkul R, et al. A simplified liquid chromatography-mass spectrometry assay for artesunate and dihydroartemisinin, its metabolite, in human plasma. Molecules (in press).
11. Tukey JW. Exploratory data analysis. Reading, MA: Addison-Wesley, 1977.
12. Simonsson US, Jansson B, Hai TN, Huong DX, Tybring G, Ashton M. Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin Pharmacol Ther 2003; 74:32-43. (Pubitemid 36776174)
13. Gordi T, Xie R, Jusko WJ. Semi-mechanistic pharmacokinetic/ pharmacodynamic modelling of the antimalarial effect of artemisinin. Br J Clin Pharmacol 2005; 60:594-604. (Pubitemid 41705378)
14. Wickramasinghe SN, Abdalla SH. Blood and bone marrow changes in malaria. Baillieres Best Pract Res Clin Haematol 2000; 13:277-299.
15. Tangpukdee N, Yew HS, Krudsood S, et al. Dynamic changes in white blood cell counts in uncomplicated Plasmodium falciparum and P. vivax malaria. Parasitol Int 2008; 57:490-494.
16. Church LW, Le TP, Bryan JP, et al. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis 1997; 175:915-920.
17. Gasasira AF, Kamya MR, Achan J, et al. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis 2008; 46:985-991.